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Abstract: Eukaryotic genome consists of long linear chromosomes. It is complex in its content and has dynamic features. It mostly consists of 
non-coding DNA of various repeats, often prone to recombination including creation of extrachromosomal DNA which can be re-integrated 
into distant parts of the genome, often in different chromosome. These events are usually part of normal genome function enabling molecular 
response to changes in the cell or organism’s environment and enabling their evolutionary development as well. These mechanisms also 
contribute to genome instability as in the case of abnormal immortalization like in cancer cells. Telomeres are among most important repetitive 
sequences, located at the end of linear chromosomes. They serve as guardians of genome stability but they also have dynamic features playing 
important role in cell aging and immortalization, both as chromosomal components or as extrachromosomal DNA. Also, recombination events 
on telomeres provide plausible explanation for stochastic nature of cell senescence, a phenomenon unjustly overlooked in broader literature. 
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EUKARYOTIC GENOME 
IZE of eukaryotic genomes often are not correlated with 
their genetic complexity. These differences do not come 
from significant variation in the number of genes but rather 
from content of several types of non-coding sequences that 
make large part of the genome. Although the number and 
the size of chromosomes differ between eukaryotic species, 
their basic structure is identical for all eukaryotes. The DNA 
and corresponding proteins in the interphase nucleus is 
called chromatin. The degree of chromatin condensation 
changes throughout the cell cycle. Part of the chromatin that 
is relaxed in the interphase is called euchromatin and mostly 
contains active genes. The remaining ∼ 10 % of the interphase 
chromatin represents heterochromatin which is condensed 
and transcriptionally suppressed because it mostly consists 
of highly repetitive DNA sequences. Thus, the structure of 
chromatin in eukaryotes is closely correlated with the control 
of gene expression. 
 During the cell division the chromatin progres-
sively condenses forming metaphase chromosomes, in 
which the DNA density increases up to 10 000 times.[1]  
THE REPETITIVE DNA CONTENT 
OF THE GENOME 
Repetitive sequences represent the most variable com-
ponent which plays significant role in the complexity and 
dynamic of eukaryotic genomes. Approximately 50 % of the 
human genome is comprised of repetitive DNA. Types of 
repetitive sequences can be determined based on the 
kinetics of their reassociation upon denaturation.[2–5] 
 Highly repetitive DNA represents ∼ 30 – 45 % of 
mammalian DNA and reassociates quickly after dena-
turation. It consists of three subgroups of repetitive DNA. i) 
Satellite DNA is usually 100 kilo base (kb) to 1 mega base 
(mb) long and spans centromeric areas. In human genome, 
alphoid satellite DNA with 171 base pairs (bp) long repeats 
occupies 3 – 5 % of the genome and represents functional 
centromeric sequence. ii) Minisatellite DNA contains 
tandem repeats ranging in length from 10 – 60 base pairs 
(bp) spanning 0.5 to several kb across the chromosome but 
more densely in centromeric and subtelomeric regions. iii) 
Microsatellites consist of short tandem repetitive units 1 to 
6 bp long and they usually do not exceed more than 150 bp 
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in length. When located in the vicinity of genes they may 
modulate their activity. 
 Sequences at the very ends of chromosomes are 
called telomeres. They represent the subgroup of short 
repeats specialized in its function to seal chromosome ends. 
 Interspersed repetitive DNA makes roughly  
25 – 40 % of mammalian DNA and reassociates slower than 
highly repetitive DNA. It includes repeats that are scattered 
throughout the genome. Often, they have the ability to 
change places and they belong to the group of mobile 
genetic elements. Two major types of mobile genetic ele-
ments in mammalian genomes are transposons and re-
trotransposons. Most common retrotransposable mobile 
elements in human genomes are long interspersed nuclear 
elements (LINEs) and short interspersed nuclear elements 
(SINEs) which are translocated by intermediateRNA. LINEs 
are 6 – 7 kb long, and SINEs are around 300 bp in length. 
While LINEs encode a functional reverse transcriptase, SINEs 
depend on reverse transcriptase encoded by other mobile 
elements. The most common representatives of LINEs and 
SINEs repeats in human genome are L1 and Alu family, 
respectively. Although LINEs and SINEs are usually located in 
the regions without genes, some of them can also be found 
within introns.[6–8] Some specialized retrotransposons serve 
as telomeres, mostly in insects, like non-LTR retrotrans-
posons, HeT-A, TART and Tahre in Drosophila melano-
gaster.[9]  
 The unique (non-repetitive) sequences or sequences 
with very little repeats occupy ∼ 50 – 60 % of mammalian 
DNA. Their reassociation after denaturation is the slowest. 
Part of the unique sequences are also most genes and 
various regulatory elements which actually build only 1 – 2 
% of entire genome. Most genes with specific function 
required in differentiated cells are present in two allelic 
copies while housekeeping genes important for basic 
metabolism and maintenance are often present in many 
copies, like clustered ribosomal genes.[10,11] 
 
EXTRACHROMOSOMAL DNA 
For a long time scientific community assumed that eukar-
yotic genome is very stable and defined regarding its 
sequence. According to this dogma, the genome was 
considered to be static and unable to immediately respond 
to environmental influences. The changes in the genome 
were considered to happen slowly over long period of time 
through evolutionary processes. As knowledge about the 
presence of various genomic sequences involved in 
amplification, repair, recombination or translocation 
processes increased, it became clear that the genome is 
much more unstable and more plastic than was previously 
thought. Often, changes in the genome structure include 
formation of extrachromosomal DNA. Indeed, in addition 
to organelle DNAs, a new population of DNA molecules, 
small in size and both linear and circular in shape has been 
identified and called extrachromosomal genomic DNA.[12–16]  
 All cells of multicellular organisms, tested so far, 
contained heterogeneous population of extrachromosomal 
circular DNA (eccDNA). Small circular DNA molecules have 
been described in various eukaryotes: Euglena,[17] 
Trypanosoma,[18] yeast,[19] fungi,[20] tobacco,[21] Drosoph-
ila,[22] Xenopus,[23] chicken,[23] mouse,[24] wild boar,[12] 
human tissue[13,25] and human fibroblasts in culture.[26,15] 
These molecules are also found in many other mammalian 
cell lines: mouse,[27] rat,[28] hamster[29] or monkey.[14] It 
appears, therefore, that the eccDNA is a general phenom-
enon in eukaryotic cells, in a similar way as the plasmids in 
prokaryotes (Table 1). 
 Usually, the total eccDNA comprises molecules of 
various sizes. Within the single cell type, circular DNA may 
vary from 500 bp to more than 85 000 bp.[30] The number 
of eccDNA molecules per cell also varies widely, from 100 
copies in human fibroblasts[31] to several thousand copies 
in monkey kidney cell line.[32]  
 
ORGANIZATION OF 
EXTRACHROMOSOMAL 
CIRCULAR DNA 
Analysis of mammalian eccDNA using hybridization and 
sequencing techniques showed that all sequences have 
homology with the chromosomal DNA, but not with the 
mitochondrial DNA. eccDNA mostly contains repetitive 
sequences such as tandem repeat DNA, like satellite DNA, 
but also mobile genetic elements (LTR retrotransposons, 
non-LTR retrotransposons) and sequences with a small 
number of copies or unique DNA (see Table 1). Most 
abundant is middle repetitive DNA fraction.[33,27] eccDNA 
derived from the alphoid satellite DNA is found in some 
unstable tumor cells like HeLa cell line but also in normal 
human diploid fibroblasts or green monkey BSC1 
cells.[34,35,26] In addition, HeLa and human cells contained 
separate groups of satellite sequences similar to alphoid 
family Sau3A.[36] Centromeric satellite sequences are fre-
quently present in eccDNA population in mouse cells in vivo 
and in vitro.[37,27]  
 
MECHANISMS OF ECCDNA 
FORMATION 
Repetitive sequences are probably involved in the for-
mation of eccDNA for several reasons; some repetitive 
sequences are mobile genetic elements, others can par-
ticipate in unequal crossing-over or intramolecular recom-
bination through which they participate in chromo-
some/genome rearrangements. Since the sequences 
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within eccDNA population are very diverse, it is reasonable 
to expect that there is more than one mechanism of their 
formation and that they can be created from a variety of 
genomic sequences. 
 Part of the DNA can be cut out of the genome and 
rounded in intrachromosomal recombination between 
repetitive sequences. First proposed mechanism for this 
event was homologous recombination between direct 
repeats.[15] Circular loop occurs when two direct repeats 
align in the orientation appropriate for homologous re-
combination. If there are more successive repeats, eccDNA 
with multiple repetitive sequences will form. Organization 
of repeats of Sau3A family and alphoid satellite DNA within 
extrachromosomal circles in human cells indicates such 
mechanism of eccDNA creation.[38,39] Investigation of cell-
free system of Xenopus laevis oocytes has shown that 
eccDNA occurs de novo, independently from replication of 
chromosomal DNA. This eccDNA is formed from sequences 
containing direct tandem repeats.[40]  
 eccDNA containing unique sequence can be created 
if homologous recombination occurs between repetitive 
sequences flanking unique one. Several eccDNA from 
mammalian cells support this model of recombination.[41] 
Circular DNA containing sequences with a small number of 
repetitions or unique sequences can occur by recombination 
of consecutive repeats without complete homology as well.[42]  
 Repeats oriented in opposite directions also contrib-
ute to recombination events and creation of eccDNA, and 
it is believed that they play an important role in gene 
amplification.[43]  
 
Since some of the eccDNA from HeLa cells that contains 
unique sequences has no direct nor inverted repeats at the 
site of recombination, it points to non-homologous 
recombination as another possible mechanism of eccDNA 
creation.[44] Some agents like cycloheximid and puromycin 
cause increase of eccDNA in cultured cells, and same effect 
was observed when the culture was kept in stationary 
phase of growth for longer period of time.[34] Agents that 
cause DNA damage have similar effects.[45]  
 
ROLE OF ECCDNA IN GENOME 
INSTABILITY 
The genome is under constant influence of destabilizing 
factors, including normal mechanisms of DNA replication 
and cell division, as well as numerous intracellular and 
extracellular stressors like oxidative metabolism or geno-
toxic agents and environmental radiation. Therefore, cells 
have developed various mechanisms in order to preserve 
integrity of the genome; especially important are high 
fidelity DNA replication, DNA damage repair and cell cycle 
control mechanisms. Any error in these processes can lead 
to destabilization of the genome, increased rate of muta-
tions or can lead to aberrant cellular functions, which ulti-
mately may cause cell death. Genomic instability rep-
resents continuous changes in the genome, which include 
various structural changes such as translocation, aneu-
ploidy, recombination, deletions, gene amplification and, 
as mentioned above, generation of eccDNA. The later one 
may not necessarily represent abnormalities. Large chro-
Table 1. Extrachromosomal circular DNA in mammalian cells[16] 
Organism Cell type or tissue 
Number of eccDNA  
per cell 
Average lengths (μm) Types of DNA 
human HeLa 50 – 200 0.8 (O.2 – 2.5) 
alphoids, Sau3A, L1,THE-1, Alu and  
unique DNA 
human fibroblasts 10 – 60 1.5 (0.1 – 7.6) alphoids, Alu, L1 
monkey kidney, cell line BSC-1 1000 – 20000 0.24 (0.05 – 1.7) alphoids, L1, Alu, and unique DNA 
hamster CHO ND 1.5 (0.09 – 7.0) 
tandem and intersperse repetitive DNA,  
unique DNA 
rat mioblasts L6 400 0.6 (0.1 – 2.5) ND 
mouse L 1200 0.6 (0.2 – 2.4) ND 
mouse 3T6 ND 0.7 (0.1 – 3.8) satellites, L1, B1 and B2 
mouse tymocites ND 5.4 (0.2 – 2.4) 
L1, B1, sequences with very little 
repeats, gen β for T-st receptor 
mouse heart ND 0.8 (0.2 – 2.4) satellites, L1, IAP, B1 and B2 
mouse liver ND ND satellites, IAP, B1 and B2 
mouse brain ND ND 
satellites, L1, IAP, 
B1 and B2 
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mosomal aberrations, such as circular and dicentric chro-
mosomes or large chromosomal deletions are usually lethal 
for dividing cell. In contrast, smaller aberrations that do not 
jeopardize cell viability are transmitted through cell 
generations. 
 Genome instability is typical for carcinogenesis and 
is often characteristic of tumor cells, while is rarely ob-
served in normal cells. It is perceived as necessary event 
that occurs early in the development of the tumor, leading 
to neoplastic transformation. Rare genetic diseases with a 
high predisposition for tumor development, such as Fan-
coni anemia, xeroderma pigmentosum and ataxia telangi-
ectasia, are characterized with defective DNA repair which 
causes genome instability accompanied with accumulation 
of eccDNA.[46,47] Also, carcinogens and substances which 
interfere with DNA synthesis increase the amount of 
eccDNA in normal human fibroblasts.[48] Thus, eccDNA is a 
good indicator of genome instability, caused either by 
endogenous mutations or harmful environmental agents.  
 
ROLE OF TELOMERES IN 
GENOME (IN)STABILITY 
Telomeres are physical ends of linear chromosomes. They 
are nucleoprotein complexes important for protection, 
replication and stabilization of chromosomes. Specific lariat 
structure of telomeres prevents chromosomal aberrations 
(translocations, deletions, chromosome fusions etc.) and 
protects the chromosome ends from DNA damage repair 
enzymes, which makes telomeres directly responsible for 
the stability of the eukaryotic genome.[49,50] Telomere 
sequence consists of repetitive TTAGGG motifs present in 
all vertebrates. They vary in size from species to species and 
in humans are on average 15 kb long.[51] Telomeres end 
with single stranded 3’-protruding end, rich in guanines, 
which is important for the formation of telomere loop (t-
loop)[52,53] (Figure 1). 
 Telomeres are dynamic structures. At each cell 
division they shorten due to the nature of DNA replication 
process at which DNA polymerase holoenzyme cannot 
synthesize the very end of linear chromosomes.[54] Thus, 
with the accumulation of cell divisions, telomeres are 
progressively shortened. Telomere shortening has been 
demonstrated both in vitro and in vivo.[49,55,56] When telo-
meres shorten to their critical length, they can no longer 
protect the ends of chromosomes. This process is of par-
ticular importance because such telomere is recognized by 
DNA damage response mechanisms which permanently 
stop cell division in the G1 phase of the cell cycle, causing 
cellular aging.[57,58] Most often, immortal cells avoid this 
scenario by expression of enzyme telomerase, specialized 
for telomere elongation.[59]  
 
EXTRACHROMOSOMAL 
CIRCULAR TELOMERE DNA 
Extrachromosomal, often circular, copies of telomere 
sequences were found in many organisms, including yeasts, 
plants, amphibians and some mammalian cell lines.[60] The 
amount of telomeric eccDNA is higher in transformed cells 
than in normal cells of rodents, and it is greatly increased 
after treatment with carcinogens. Telomeric eccDNA is 
detected in some human tumors and cell lines, which 
suggests that it is not common phenomenon in 
transformed human cells. Research on human immortal cell 
lines without active telomerase, which use alternative 
mechanism based on recombination to extend their telo-
meres (ALT)[61] showed the presence of small linear[62,63] 
and circular double strand eccDNA with telomeric se-
quences in both the cytoplasm and nucleus, while these 
were not observed in normal fibroblasts.[64] Telomere 
eccDNA found in the nucleus is in complex with telomere 
binding proteins like telomere repeat factor 1 (TRF1), 
telomere repeat factor 2 (TRF2) but also with recombina-
tion Mre11-Rad50-Nbs1 (MRN) complex.[63] It was found in 
cells from patients with ataxia telangiectasia disease, 
defective in DNA repair.[65]  
 Telomere sequences present as eccDNA are consid-
ered to be indicator of genomic instability,[66] but they 
also may have an important role in maintaining telomere 
 
Figure 1. Telomere loop structure (see text for details). 
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length in some cells.[67] The existence of eccDNA with telo-
meric sequences is explained with intra-homologous 
recombination between telomere repeats, an intra-ho-
mologous recombination within telomere loop (t-loop) or 
circularization of extrachromosomal linear telomeric 
DNA[60] (Figure 2 A, B, C, respectively). An example of such 
recombination event in the cell is shown in Figure 2 D. 
 
ROLE OF EXTRACHROMOSOMAL 
CIRCULAR TELOMERE DNA IN 
CELL SENESCENCE 
Early experiments have shown that the populations of 
normal human fibroblasts in culture are very heterogene-
ous regarding their cell growth potential.[68] On individual 
cell level, even two daughter cells arising from the same 
mitosis show great variation in population doublins 
(PDs).[69] These results could not be explained by the grad-
ual shortening of telomeres due to incomplete replication 
of chromosome ends. A theoretical model of abrupt telo-
mere shortening (ATS), has been proposed which predicts 
recombination event on telomeres in normal human 
cells.[70,71] As a result, extrachromosomal circular telomere 
DNA or t-circles, are formed. Most common method for 
detection of t-circles is two-dimensional (2D) gel electro-
phoresis. This method showed presence of t-circles in some 
tumor cell lines, human fibroblasts carrying mutations on 
certain genes associated with telomeres and hTERT 
immortalized cells,[48,64,72–76] but still it never showed their 
presence in normal human cells.[72]  
 Using reaction for amplification of telomeric circular 
DNA, which is ten times more sensitive than 2D gel elec-
trophoresis, we were able to detect t-circles in normal 
human skin fibroblasts MJ90 and normal human lung 
fibroblasts IMR90.[77] Unlike in ALT U2OS cells where  
t-circles can easily be detected by 2D gel electrophore-
sis,[73,72] their low presence in human fibroblasts MJ90 
showed that rapid telomere deletion is a rare event in 
normal cells. A rough estimate shows that only less than 
0,005 % of telomeres can undergo abrupt shortening per 
one cell division in these cells which is below the level of 
detection of 2D gel electrophoresis. Nevertheless, simula-
tion of abrupt telomere shortening showed that these rare 
events have a major impact on the growth dynamics of 
normal cell cultures.[78,71] Analysis of total telomere length 
in fractions of young and old cells isolated from the same 
culture showed that the average telomere length in these 
two fractions is the same. This supports the idea that 
stochastic appearance of senescent cells in normal cell 
culture is a consequence of abrupt telomere shortening 
rather than gradual loss of telomere repeats.[66]  
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